4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
10.56
+0.68 (6.88%)
Mar 26, 2026, 11:53 AM EDT - Market open
4D Molecular Therapeutics Market Cap
4D Molecular Therapeutics has a market cap or net worth of $539.1 million as of March 26, 2026. Its market cap has increased by 183.29% in one year.
Market Cap
539.10M
Enterprise Value
11.77M
1-Year Change
183.29%
Ranking
Category
Stock Price
$10.56
Market Cap Chart
Since the IPO on December 11, 2020, 4D Molecular Therapeutics's market cap has decreased from $580.38M to $539.10M, a decrease of -7.11%. That is a compound annual growth rate of -1.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 504.39M | 17.71% |
| Dec 31, 2025 | 428.51M | 66.42% |
| Dec 31, 2024 | 257.49M | -70.27% |
| Dec 29, 2023 | 866.19M | 20.40% |
| Dec 30, 2022 | 719.43M | 2.03% |
| Dec 31, 2021 | 705.13M | -35.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zevra Therapeutics | 536.04M |
| Zura Bio | 533.23M |
| CorMedix | 522.52M |
| Upstream Bio | 511.75M |
| Rocket Pharmaceuticals | 508.10M |
| ADC Therapeutics | 504.37M |
| Prothena Corporation | 501.19M |
| Contineum Therapeutics | 495.82M |